Learn more about study-related clinical care options for OCD.

DO YOU HAVE OCD AND ARE STRUGGLING TO FIND EFFECTIVE TREATMENT?

This study is evaluating the efficacy of a new medication as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment. Study sponsored by Biohaven Pharmaceuticals in collaboration with NOCD.

Length of Study: 12-18 weeks with 7 on-site visits 

ELIGIBILITY:

You may be eligible to participate in this study if you:

• are between the ages of 18-65
• have been diagnosed with OCD
• have been experiencing symptoms of OCD for at least one year
• are currently taking an SSRI (antidepressant medication)

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed. Apply now.